GO:0140208 apoptotic process in response to mitochondrial fragmentation: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140208 describes apoptosis that is triggered as a direct consequence of mitochondrial fragmentation, linking mitochondrial dynamics to cell death.
• Mitochondrial fragmentation is often mediated by dynamin-related protein 1 (DRP1) and its receptors, including mitochondrial fission factor (MFF), which can be influenced by lipid signals such as ceramides.
• The process is distinct from general apoptosis because it requires upstream mitochondrial fission events, as shown in neurons treated with Bcl-2 antagonists and in excitotoxic models.
• Mitophagy can counteract mitochondrial fragmentation and modulate apoptosis during differentiation and stress.
• Dysregulation of this process contributes to cardiovascular injury, neurodegeneration, and drug-induced hepatotoxicity.
• Experimental models include knockout of fission/fusion genes, point mutations in DRP1, and live-cell imaging of mitochondrial morphology and apoptosis.
Description
Mitochondria are dynamic organelles that continuously undergo fusion and fission, and an imbalance toward fission leads to mitochondrial fragmentation. When fragmentation becomes pronounced, it can directly initiate or amplify apoptotic signaling, a phenomenon captured by the Gene Ontology term GO:0140208, apoptotic process in response to mitochondrial fragmentation. This term is used to annotate biological processes in which mitochondrial fragmentation is a causal event leading to apoptosis, rather than a secondary consequence. Understanding this process is critical because it sits at the intersection of mitochondrial dynamics, cell death, and human disease. For example, in obesity-associated metabolic stress, ceramide synthesis by CerS6 promotes mitochondrial fragmentation through interaction with MFF, which can sensitize cells to apoptosis. In neurons, different death stimuli converge on mitochondrial fragmentation, but the pathways may differ between apoptotic and excitotoxic death. The term also has clinical relevance: mitochondrial fragmentation is observed in cardiovascular disease, ischemia/reperfusion injury, and drug-induced liver injury, where apoptosis contributes to tissue damage. Researchers studying this process need reliable models to dissect the molecular players and to test whether fragmentation is a cause or consequence of apoptosis. This article provides a research-grade overview of GO:0140208, including its definition, core mechanisms, key genes, disease links, and experimental strategies.
apoptotic process in response to mitochondrial fragmentation At A Glance
| GO ID | GO:0140208 |
|---|---|
| GO term | apoptotic process in response to mitochondrial fragmentation |
| Ontology | biological_process |
| Synonym | apoptosis in response to mitochondrial fragmentation |
| Definition | Any apoptotic process that occurs as a result of mitochondrial fragmentation. |
| Major function | Coupling mitochondrial fission/fragmentation to apoptotic cell death |
| Related processes | Mitochondrial dynamics, mitophagy, intrinsic apoptosis |
| Key regulators | DRP1, MFF, BAX/BAK, ceramides |
| Disease relevance | Cardiovascular disease, neurodegeneration, hepatotoxicity |
What Is GO:0140208?
GO:0140208, apoptotic process in response to mitochondrial fragmentation, is defined as any apoptotic process that occurs as a result of mitochondrial fragmentation. In other words, it is a subtype of programmed cell death in which the initiating or required upstream event is the physical fragmentation of the mitochondrial network. This distinguishes it from apoptosis that occurs independently of mitochondrial morphology changes. The term is a biological process and includes the signaling events that link fragmented mitochondria to caspase activation, cytochrome c release, and other hallmarks of apoptosis.
Why Is apoptotic process in response to mitochondrial fragmentation Important in Cell Biology?
GO:0140208 is important because it provides a precise framework for studying how changes in mitochondrial shape directly cause cell death. Many pathological conditions, including myocardial ischemia/reperfusion injury, neurodegeneration, and acetaminophen-induced liver injury, involve mitochondrial fragmentation and apoptosis. By annotating this process, researchers can distinguish it from general apoptosis and focus on the upstream fission machinery as a therapeutic target. Moreover, the term helps integrate findings from diverse fields such as metabolism, neuroscience, and cardiology, where mitochondrial dynamics are increasingly recognized as central to disease pathogenesis.
• Provides a causal link between mitochondrial morphology and apoptosis, distinguishing it from apoptosis that occurs independently of fragmentation.
• Implicates DRP1 and its receptors (MFF, FIS1, MIEF1/2) as potential therapeutic targets in diseases with excessive fission.
• Explains how metabolic signals, such as ceramide accumulation in obesity, can trigger apoptosis via fragmentation.
• Highlights the protective role of mitophagy in limiting fragmentation-induced apoptosis during differentiation and stress.
• Relevant to cardiovascular disease, where mitochondrial fragmentation contributes to cardiomyocyte death.
• Contributes to neuronal death in excitotoxicity and apoptosis, with distinct pathways depending on the stimulus.
• Underlies drug-induced hepatotoxicity, such as acetaminophen overdose, where mitochondrial fragmentation precedes apoptosis.
• Offers biomarkers for assessing mitochondrial health and apoptosis in preclinical models.
• Guides development of fission inhibitors (e.g., Mdivi-1) as potential cytoprotective agents.
• Enables precise genetic dissection using CRISPR knockout of fission/fusion genes to test causality.
What Happens During apoptotic process in response to mitochondrial fragmentation?
Initiation of mitochondrial fragmentation
In simple terms: The mitochondrial network breaks into smaller pieces.
Mitochondrial fragmentation is initiated by recruitment of DRP1 from the cytosol to the outer mitochondrial membrane, where it binds receptors such as MFF, FIS1, and MIEF1/2. This process can be triggered by various stresses, including ceramide accumulation, Bcl-2 family antagonist treatment, and excitotoxicity. In obesity, CerS6-derived sphingolipids interact with MFF to promote fragmentation. The fragmentation itself is a required upstream event for the subsequent apoptotic cascade in the context of GO:0140208.
Mitochondrial outer membrane permeabilization (MOMP)
In simple terms: The fragmented mitochondria leak death signals.
Following fragmentation, pro-apoptotic Bcl-2 family proteins such as BAX and BAK are activated and oligomerize on the outer mitochondrial membrane, leading to MOMP. This releases cytochrome c and other apoptogenic factors. Studies in neurons show that ABT-737, a Bcl-2/Bcl-xL/Bcl-w antagonist, induces mitochondrial fragmentation and apoptosis, linking fragmentation to MOMP. The exact order may vary by cell type, but fragmentation often precedes or coincides with MOMP in this process.
Caspase activation and apoptosis
In simple terms: The cell dismantles itself.
Cytochrome c release triggers apoptosome formation and activation of caspase-9, followed by executioner caspases-3 and -7. This leads to the morphological and biochemical hallmarks of apoptosis. In the context of GO:0140208, this caspase activation is a downstream consequence of mitochondrial fragmentation. Neutrophil apoptosis assays can be used to monitor these events.
Regulation by mitophagy
In simple terms: The cell can clean up fragmented mitochondria to avoid death.
Mitophagy, the selective autophagic removal of damaged mitochondria, can counteract fragmentation-induced apoptosis. During myoblast differentiation, mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis. Inhibition of mitophagy, as seen with NR4A1-mediated suppression of FUNDC1-dependent mitophagy in myocardial ischemia/reperfusion, exacerbates fragmentation and apoptosis. Thus, the balance between fragmentation and mitophagy determines cell fate.
Key Genes Involved in GO:0140208 apoptotic process in response to mitochondrial fragmentation
The following genes and proteins are central to the regulation and execution of apoptotic process in response to mitochondrial fragmentation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DRP1 (DNM1L) | GTPase that mediates mitochondrial fission | Knockout or dominant-negative mutants block fragmentation and apoptosis |
| MFF | Outer mitochondrial membrane receptor for DRP1 | Ceramide interaction promotes fragmentation in obesity |
| FIS1 | DRP1 receptor, promotes fission | Overexpression induces fragmentation and apoptosis |
| MIEF1/2 | DRP1 receptors, can inhibit or promote fission | Regulate fission dynamics |
| BAX | Pro-apoptotic Bcl-2 protein, mediates MOMP | Knockout delays apoptosis after fragmentation |
| BAK | Pro-apoptotic Bcl-2 protein, mediates MOMP | Required for MOMP in many cell types |
| BCL2 | Anti-apoptotic, inhibits MOMP | Overexpression prevents fragmentation-induced apoptosis |
| BCL2L1 (Bcl-xL) | Anti-apoptotic, inhibits MOMP | Targeted by ABT-737 to induce fragmentation and apoptosis |
| CERS6 | Ceramide synthase 6, produces C16-ceramide | Promotes MFF interaction and fragmentation in obesity |
| NR4A1 | Nuclear receptor, induces MFF and inhibits mitophagy | Promotes myocardial ischemia/reperfusion injury |
| FUNDC1 | Mitophagy receptor | Inhibition by NR4A1 exacerbates fragmentation |
| PINK1 | Mitophagy kinase | Mutated in Parkinson's disease, affects fragmentation |
| PRKN (Parkin) | E3 ubiquitin ligase for mitophagy | Mutations linked to neurodegeneration |
| CYCS | Cytochrome c, released upon MOMP | Marker of apoptosis |
| CASP3 | Executioner caspase | Cleaves substrates during apoptosis |
| CASP9 | Initiator caspase in intrinsic apoptosis | Activated by cytochrome c |
| MAP1LC3B | Autophagosome marker | Monitors mitophagy |
How Is apoptotic process in response to mitochondrial fragmentation Regulated?
The process of apoptotic process in response to mitochondrial fragmentation is regulated at multiple levels. Upstream, mitochondrial fission is controlled by post-translational modifications of DRP1, such as phosphorylation by CDK1/cyclin B and dephosphorylation by calcineurin, which promote its mitochondrial recruitment. Lipid signaling, particularly ceramide synthesis by CerS6, enhances MFF-DRP1 interaction and fragmentation. Mitophagy acts as a counter-regulatory mechanism; for instance, FUNDC1-dependent mitophagy can remove fragmented mitochondria and limit apoptosis, and its inhibition by NR4A1 exacerbates injury. Bcl-2 family proteins integrate these signals: anti-apoptotic BCL2 and BCL2L1 inhibit MOMP, while BAX and BAK promote it. Additionally, during myoblast differentiation, mitophagy regulates oxidative stress and apoptosis, highlighting developmental control.
apoptotic process in response to mitochondrial fragmentation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NR4A1 | Myocardial ischemia/reperfusion injury | Cardiomyocyte-specific knockout or overexpression in mice |
| CERS6 | Obesity-associated metabolic stress | CerS6 knockout mice or cell lines |
| PINK1 | Parkinson's disease | PINK1 knockout neurons or patient-derived iPSCs |
| PRKN | Parkinson's disease | PRKN knockout models |
| DRP1 (DNM1L) | Cardiovascular and neurodegenerative diseases | DRP1 knockout or dominant-negative mutants |
Cardiovascular disease and ischemia/reperfusion injury
Mitochondrial fragmentation is a hallmark of cardiomyocyte death in ischemia/reperfusion injury. NR4A1 promotes myocardial ischemia/reperfusion injury by inducing MFF-mediated mitochondrial fragmentation and inhibiting FUNDC1-dependent mitophagy. This leads to increased apoptosis and infarct size. Mitochondrial morphology is also altered in various cardiovascular diseases, making fission machinery a therapeutic target.
Neurodegeneration and neuronal death
In neurons, mitochondrial fragmentation occurs during apoptotic and excitotoxic cell death, although the pathways may differ. ABT-737, a Bcl-2 antagonist, induces mitochondrial fragmentation and neuronal apoptosis, implicating the intrinsic pathway. Defects in mitophagy, as seen with PINK1 or PRKN mutations, can lead to accumulation of fragmented mitochondria and neuronal loss in Parkinson's disease.
Drug-induced hepatotoxicity
Acetaminophen overdose causes mitochondrial fragmentation and apoptosis in hepatocytes, contributing to acute liver failure. The process involves DRP1-mediated fission and is a target for protective strategies. Understanding GO:0140208 in this context can guide development of therapies that preserve mitochondrial integrity.
From apoptotic process in response to mitochondrial fragmentation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DRP1 block fragmentation-induced apoptosis? | DRP1 knockout cell line (e.g., HeLa, MEFs) |
| Does a point mutation in DRP1 affect GTPase activity and fragmentation? | CRISPR knock-in of DRP1 K38A or other mutants |
| Does CerS6-mediated ceramide production promote MFF interaction? | CerS6 overexpression or knockout in adipocytes |
| Does mitophagy counteract fragmentation-induced apoptosis? | FUNDC1 knockout or overexpression in cardiomyocytes |
| Can Bcl-2 overexpression prevent apoptosis after fragmentation? | BCL2 transgenic mice or stable cell lines |
| Does NR4A1 regulate MFF and mitophagy in vivo? | Cardiomyocyte-specific NR4A1 knockout mice |
How to Study the apoptotic process in response to mitochondrial fragmentation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell confocal microscopy | Mitochondrial morphology dynamics | Monitor fragmentation before apoptosis |
| Annexin V/PI flow cytometry | Phosphatidylserine exposure and membrane integrity | Quantify apoptosis |
| Caspase-3/7 activity assay | Executioner caspase activity | Confirm apoptosis induction |
| Mito-Keima | Mitophagy flux | Assess autophagic removal of mitochondria |
| Western blot | Protein levels (DRP1, MFF, BAX, etc.) | Validate knockout or overexpression |
| Immunofluorescence | Localization of DRP1, cytochrome c | Detect MOMP and fission |
| Seahorse assay | Mitochondrial respiration | Link fragmentation to metabolic changes |
| Electron microscopy | Ultrastructure of mitochondria | Visualize fragmentation and cristae changes |
Live-cell imaging of mitochondrial morphology
Fluorescent labeling of mitochondria (e.g., MitoTracker, mito-GFP) allows real-time monitoring of fragmentation and apoptosis. This method is essential to confirm that fragmentation precedes cell death in GO:0140208.
Apoptosis assays
Annexin V/propidium iodide staining, caspase-3/7 activity assays, and TUNEL staining quantify apoptosis. Neutrophil apoptosis protocols provide a standardized approach.
Mitophagy flux analysis
LC3B turnover, mito-Keima, and electron microscopy assess mitophagy. These methods help determine whether mitophagy regulates fragmentation-induced apoptosis.
Genetic manipulation with CRISPR
CRISPR knockout, knock-in, and overexpression models enable causal testing of genes like DRP1, MFF, and CERS6 in the process.
How CRISPR Can Be Used to Study GO:0140208 apoptotic process in response to mitochondrial fragmentation
Knockout
CRISPR knockout of DRP1, MFF, or CERS6 can block mitochondrial fragmentation and prevent apoptosis, establishing causality in GO:0140208. Knockout of anti-apoptotic genes like BCL2 can sensitize cells to fragmentation-induced death.
Point Mutation
Knock-in of point mutations in DRP1 (e.g., K38A) or MFF can dissect domain-specific functions in fragmentation and apoptosis. Such models help distinguish GTPase activity from protein-protein interactions.
Knock-in
Tagged knock-in of DRP1 or MFF with fluorescent proteins enables live tracking of fission events and their link to apoptosis. Knock-in of disease-associated mutations can model human pathology.
Overexpression
Overexpression of MFF, FIS1, or CERS6 induces fragmentation and apoptosis, providing gain-of-function models. Conversely, overexpression of BCL2 or FUNDC1 can protect against fragmentation-induced death.
How EDITGENE Supports apoptotic process in response to mitochondrial fragmentation Research
Researchers studying apoptotic process in response to mitochondrial fragmentation-related genes often need to determine whether a candidate gene is causally involved in fragmentation-induced apoptosis or merely a bystander. This requires precise genetic models that can manipulate gene function in a controlled manner. EDITGENE provides a comprehensive suite of CRISPR services to accelerate such studies, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for apoptotic process in response to mitochondrial fragmentation research.
Frequently Asked Questions About apoptotic process in response to mitochondrial fragmentation
What is GO:0140208?
GO:0140208 is the Gene Ontology term for apoptotic process in response to mitochondrial fragmentation, defined as any apoptotic process that occurs as a result of mitochondrial fragmentation.
What genes are involved in apoptotic process in response to mitochondrial fragmentation?
Key genes include DRP1 (DNM1L), MFF, FIS1, BAX, BAK, BCL2, CERS6, and NR4A1, among others.
How does mitochondrial fragmentation lead to apoptosis?
Fragmentation promotes mitochondrial outer membrane permeabilization (MOMP), releasing cytochrome c and activating caspases, which execute apoptosis.
What is the role of DRP1 in this process?
DRP1 is the master GTPase that mediates mitochondrial fission; its recruitment to mitochondria is required for fragmentation and subsequent apoptosis.
Can mitophagy prevent apoptosis caused by mitochondrial fragmentation?
Yes, mitophagy can remove fragmented mitochondria and limit apoptosis, as shown in myoblast differentiation and cardiac injury models.
Which diseases are associated with apoptotic process in response to mitochondrial fragmentation?
Cardiovascular disease, neurodegeneration, and drug-induced hepatotoxicity are linked to this process.
How can I study mitochondrial fragmentation and apoptosis in the lab?
Use live-cell imaging with MitoTracker, apoptosis assays (Annexin V, caspase activity), and CRISPR knockout models.
What experimental models are available for GO:0140208?
Models include DRP1 knockout cells, MFF overexpression, CerS6 knockout mice, and NR4A1 knockout cardiomyocytes.
What is the difference between apoptosis and apoptotic process in response to mitochondrial fragmentation?
The latter specifically requires mitochondrial fragmentation as the initiating or required event, whereas general apoptosis can occur without it.
How does ceramide signaling link to mitochondrial fragmentation?
CerS6-derived ceramides interact with MFF to promote DRP1-mediated fragmentation, sensitizing cells to apoptosis in obesity.
Conclusion
GO:0140208, apoptotic process in response to mitochondrial fragmentation, captures a critical mechanism linking mitochondrial dynamics to cell death. It is driven by fission machinery such as DRP1 and MFF, regulated by mitophagy and Bcl-2 family proteins, and implicated in cardiovascular disease, neurodegeneration, and hepatotoxicity. Understanding this process requires precise genetic models and imaging techniques. EDITGENE offers comprehensive CRISPR solutions to dissect the causal roles of genes in this pathway, empowering researchers to develop targeted therapies.
References
- 1. Hammerschmidt P et al.. 2019. CerS6-Derived Sphingolipids Interact with Mff and Promote Mitochondrial Fragmentation in Obesity.. Cell 177(6):1536-1552.e23 PMID: 31150623
- 2. Baechler BL et al.. 2019. Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation.. Autophagy 15(9):1606-1619 PMID: 30859901
- 3. Ramachandran A et al.. 2019. Acetaminophen Hepatotoxicity.. Semin Liver Dis 39(2):221-234 PMID: 30849782
- 4. Barth ND et al.. 2020. Assessment of Neutrophil Apoptosis.. Methods Mol Biol 2087:167-190 PMID: 31728991
- 5. Ong SB et al.. 2010. Mitochondrial morphology and cardiovascular disease.. Cardiovasc Res 88(1):16-29 PMID: 20631158
- 6. Wang J et al.. 2024. Nuclear receptor subfamily 4 group A member 1 promotes myocardial ischemia/reperfusion injury through inducing mitochondrial fission factor-mediated mitochondrial fragmentation and inhibiting FUN14 domain containing 1-depedent mitophagy.. Int J Biol Sci 20(11):4458-4475 PMID: 39247823
- 7. Young KW et al.. 2010. Mitochondrial fragmentation and neuronal cell death in response to the Bcl-2/Bcl-x(L)/Bcl-w antagonist ABT-737.. Neuropharmacology 58(8):1258-67 PMID: 20307556
- 8. Young KW et al.. 2010. Different pathways lead to mitochondrial fragmentation during apoptotic and excitotoxic cell death in primary neurons.. J Biochem Mol Toxicol 24(5):335-41 PMID: 20201108
